Podcast
Questions and Answers
What is the primary use of Desonide in dermatology?
What is the primary use of Desonide in dermatology?
- To increase vasodilation
- To promote wound healing
- To stimulate cytokine release
- To reduce swelling and redness (correct)
How does Desonide suppress inflammation?
How does Desonide suppress inflammation?
- By increasing vasodilation
- By promoting leukocyte migration
- By inhibiting cytokine release (correct)
- By enhancing immune cell activity
In a clinical trial evaluating vasoconstrictive properties, Desonide Gel 0.05% was compared to all of the following EXCEPT:
In a clinical trial evaluating vasoconstrictive properties, Desonide Gel 0.05% was compared to all of the following EXCEPT:
- DesOwen Lotion (desonide lotion 0.05%)
- Cyclocort Cream (amcinonide 0.1%)
- Triamcinolone acetonide cream 0.1% (correct)
- Hydrocortisone cream 0.5% (low potency)
What is the main mechanism of action of Desonide in reducing redness?
What is the main mechanism of action of Desonide in reducing redness?
Which of the following is NOT a formulation in which Desonide is available?
Which of the following is NOT a formulation in which Desonide is available?
How does Desonide modulate the immune response in the skin?
How does Desonide modulate the immune response in the skin?
What was the objective of the clinical trial-3?
What was the objective of the clinical trial-3?
What was the outcome of the clinical trial-4?
What was the outcome of the clinical trial-4?
What is the purpose of comparing Desonide with other topical corticosteroids or non-steroidal alternatives in some trials?
What is the purpose of comparing Desonide with other topical corticosteroids or non-steroidal alternatives in some trials?
What was the study design for Clinical trial-2?
What was the study design for Clinical trial-2?
What was the gender distribution in the study designed to compare the vasoconstriction effect of Desonide formulation?
What was the gender distribution in the study designed to compare the vasoconstriction effect of Desonide formulation?
What was observed in the study designed to compare the vasoconstriction effect of Desonide formulation?
What was observed in the study designed to compare the vasoconstriction effect of Desonide formulation?
What was the main focus of Clinical trial-2?
What was the main focus of Clinical trial-2?
What is being compared in Clinical trial-3?
What is being compared in Clinical trial-3?
What was observed in Clinical trial-2 after four weeks of twice-daily applications?
What was observed in Clinical trial-2 after four weeks of twice-daily applications?
